Unfolding like 100 years of home video footage that were shot by the family ghosts, Mascha Schilinski’s rich and mesmeric “ ...

Deep dive into RBAC vs ReBAC for enterprise sso. Learn which authorization model fits your ciam strategy and how to avoid role explosion in complex apps.

AI chipmaker Nvidia (NVDA) and pharmaceutical giant Eli Lilly (LLY) on Monday announced that the two companies would jointly invest $1 billion to create a lab in San Francisco focused on using AI to ...

The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, creating an experience that will have you wondering why you waited so long to ...

The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, drawing movie lovers from Broken Arrow to Bartlesville and beyond. Remember ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

String Metaverse Limited, formerly Bio Green Papers Limited, is an India-based Web 3.0 company. The Company is at the forefront of blockchain technology, offering gaming platforms, digital advisory ...

"Data As Of" refers to the Closing Sale. Volume is updated throughout the after hours market. Note: Daily closing values are valid as of 5:15 p.m. ET. Duplicate values disseminated after 5:15 p.m. ET.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...